Irbesartan does not affect the steady-state pharmacodynamics and pharmacokinetics of warfarin

被引：0

作者：

B. Mangold

W. Gielsdorf

M. R. Marino

机构：

[1] Bristol-Myers Squibb Pharmaceutical Research Institute,

[2] Waterloo Office Park,undefined

[3] 161 Drive Richelle,undefined

[4] Box 30,undefined

[5] 1410 Waterloo,undefined

[6] Belgium Tel.: +32-2-3527651; Fax: +32-2-3514013,undefined

[7] Bristol-Myers Squibb Pharmaceutical Research Institute,undefined

[8] Princeton,undefined

[9] NJ,undefined

[10] USA,undefined

来源：

European Journal of Clinical Pharmacology | 1999年 / 55卷

关键词：

Key words Irbesartan; Warfarin; Pharmacokinetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objectives: To determine whether the initiation or titration of irbesartan alters the pharmacodynamics and/or pharmacokinetics of warfarin in a clinically significant manner, thereby requiring additional monitoring of the anticoagulant effect of warfarin.

引用

页码：593 / 598

页数：5